A randomized study (WOS MM1) comparing the oral regime Z-Dex (idarubicin and dexamethasone) with vincristine, adriamycin and dexamethasone as induction therapy for newly diagnosed patients with multiple myeloma.

G. Cook, R.E. Clark, T Morris, M. Robertson, N.P. Lucie, S. Anderson, J. Paul, I.M. Franklin

Research output: Contribution to journalArticle

17 Citations (Scopus)
Original languageEnglish
Pages (from-to)792-798
Number of pages7
JournalBritish Journal of Haematology
Volume126(6)
Issue number6
DOIs
Publication statusPublished - Sep 2004

ASJC Scopus subject areas

  • Hematology

Cite this